IL2RA is associated with multiple autoimmune diseases including type 1 diabetes (T1D).
3
Common variants of the gene IL2RA encoding CD25, the alpha chain of the IL-2 receptor, are associated with multiple autoimmune diseases including type 1 diabetes 1 (T1D) and multiple sclerosis 2, 3 (MS). The IL2RA genetic association is influenced by several distinct haplotypes, with the most protective T1D haplotype shared between T1D (odds ratio (OR) = 0.63) and MS (OR = 0.85) and termed "group A" 3 . The group A haplotype is defined by eight SNPs in high linkage disequilibrium (LD) (Supplementary Table 1 ) 3 , including SNPs rs12722495 and rs61839660 that correlate with higher CD25 expression on CD4 + memory T cells when the minor alleles are present [4] [5] [6] . One study demonstrated increased IL2RA mRNA from the A haplotype in the same cell type 4 , with the effect large enough to be seen as an eQTL in whole blood 7 , and the same SNP correlating with a cis-meQTL 250 bp distal of the IL2RA transcriptional start site 8 . Although SNPs in the group A haplotype have been identified as the most associated in genetic association studies of T1D 1, 9 and Crohn's disease (rs61839660) 10 as well as juvenile idiopathic arthritis (rs7909519) 11 , owing to the high degree of LD amongst the eight SNPs (minimum pairwise r 2 =0.65), the most associated SNP is not necessarily the causal variant 12 , and resolution of high LD between the most diseaseassociated variants in a region remains a major barrier to causal variant identification.
Epigenetic evidence suggests rs6183990 as the most likely causal variant as analysis of the ENCODE 13 and Roadmap Epigenetic 14 databases showed that it was the only A haplotype SNP that lies within conserved DNA sequence with potential enhancer activity in CD4 + T cells (Fig. 1a, Supplementary Fig. 1 Fig. 1c ), a level close to that from the genomic DNA control (allelic ratio ~1 at rs12722495 and rs12244380 Fig. 1b,c) .
From within the Cambridge BioResource, we identified one recallable donor out of 2,748 individuals heterozygous for the A -660 and A haplotypes. ASE was performed using mRNA from purified CD4 + central memory T cells using only the reporter SNP rs12244380 since the donor was homozygous at rs12722495. Compared to cells from two A-homozygous donors, which displayed nearly equal mRNA expression from both alleles, cells from the A -660 x A donor produced approximately twice the amount of IL2RA mRNA from the A allele as compared to the A -660 allele (Fig. 1d) . haplotype, we next tested the A -660 haplotype for T1D disease association. Despite the rarity of A -660 haplotypes, we observed lower protection from T1D for the A -660 compared to the A haplotype (OR = 1.37, CI=1.015-1.840, p=0.04, Supplementary Fig. 5 ).
Our study demonstrates the power of using quantitative measurements of allele-specific mRNA production from rare haplotypes present in the human population as a method to resolve the high LD between the most disease-associated variants in order to identify the causal variant. The A -660 haplotype is reminiscent of a natural CRISPR experiment, with the advantage that accessible cell types can be purified and analysed ex vivo in a physiological context. The fact that both the A and A -660 haplotypes have been maintained in some human 6 populations but not others (Fig. 1e) is shown in Supplementary Fig. 2 . Non-A haplotypes are those not having any of the T1D-protective alleles at the eight group A SNPs. The red lines represent the mean with SD. P values were calculated using a Wilcoxon rank sum test.
